Biotricity Inc. (OTCQB: BTCY) announced on July 15, 2025, that it expects to report a shift to positive Adjusted EBITDA for its fiscal year 2025. This pre-announcement comes ahead of the full financial results for the fourth quarter and fiscal year.
The company highlighted continued improvements in margins and operational efficiency. Management stated that this represents the best financial performance thus far, indicating strong progress towards profitability.
This positive outlook for the full fiscal year underscores the company's commitment to redefining healthcare with state-of-the-art remote monitoring and diagnostic solutions. Investors will look for confirmation of these metrics in the upcoming earnings report.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.